Goldman Sachs Upgrades Seattle Genetics (SGEN) to Neutral
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Goldman Sachs upgraded Seattle Genetics (NASDAQ: SGEN) from Sell to Neutral with a price target of $47.00 (from $30.00).
Shares of Seattle Genetics closed at $54.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Upgrades Juniper Networks (JNPR) to Outperform
- Western Digital (WDC) PT Raised to $100 at Brean Capital on Way to $120
- Deutsche Bank Downgrades MGM Growth Properties (MGP) to Hold
Create E-mail Alert Related CategoriesAnalyst PT Change, Upgrades
Related EntitiesGoldman Sachs
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!